3.26.1 html 259 346 1 false 93 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.silopharma.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.silopharma.com/role/ConsolidatedBalanceSheet Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.silopharma.com/role/ConsolidatedBalanceSheet_Parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.silopharma.com/role/ConsolidatedIncomeStatement Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes In Stockholders??? Equity Sheet http://www.silopharma.com/role/ShareholdersEquityType2or3 Consolidated Statements of Changes In Stockholders??? Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Changes In Stockholders??? Equity (Parentheticals) Sheet http://www.silopharma.com/role/ShareholdersEquityType2or3_Parentheticals Consolidated Statements of Changes In Stockholders??? Equity (Parentheticals) Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.silopharma.com/role/ConsolidatedCashFlow Consolidated Statements of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Organization and Business Sheet http://www.silopharma.com/role/OrganizationandBusiness Organization and Business Notes 8 false false R9.htm 008 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.silopharma.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements Sheet http://www.silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements Fair Value of Financial Instruments and Fair Value Measurements Notes 10 false false R11.htm 010 - Disclosure - Crypto Assets Sheet http://www.silopharma.com/role/CryptoAssets Crypto Assets Notes 11 false false R12.htm 011 - Disclosure - Intangible Assets Sheet http://www.silopharma.com/role/IntangibleAssets Intangible Assets Notes 12 false false R13.htm 012 - Disclosure - Stockholders??? Equity Sheet http://www.silopharma.com/role/StockholdersEquity Stockholders??? Equity Notes 13 false false R14.htm 013 - Disclosure - Concentrations Sheet http://www.silopharma.com/role/Concentrations Concentrations Notes 14 false false R15.htm 014 - Disclosure - Commitments and Contingencies Sheet http://www.silopharma.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 15 false false R16.htm 015 - Disclosure - Income Taxes Sheet http://www.silopharma.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 016 - Disclosure - Subsequent Events Sheet http://www.silopharma.com/role/SubsequentEvents Subsequent Events Notes 17 false false R18.htm 996000 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.silopharma.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.silopharma.com/role/SummaryofSignificantAccountingPolicies 18 false false R19.htm 996001 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.silopharma.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.silopharma.com/role/SummaryofSignificantAccountingPolicies 19 false false R20.htm 996002 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements (Tables) Sheet http://www.silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurementsTables Fair Value of Financial Instruments and Fair Value Measurements (Tables) Tables http://www.silopharma.com/role/FairValueofFinancialInstrumentsandFairValueMeasurements 20 false false R21.htm 996003 - Disclosure - Crypto Assets (Tables) Sheet http://www.silopharma.com/role/CryptoAssetsTables Crypto Assets (Tables) Tables http://www.silopharma.com/role/CryptoAssets 21 false false R22.htm 996004 - Disclosure - Intangible Assets (Tables) Sheet http://www.silopharma.com/role/IntangibleAssetsTables Intangible Assets (Tables) Tables http://www.silopharma.com/role/IntangibleAssets 22 false false R23.htm 996005 - Disclosure - Stockholders??? Equity (Tables) Sheet http://www.silopharma.com/role/StockholdersEquityTables Stockholders??? Equity (Tables) Tables http://www.silopharma.com/role/StockholdersEquity 23 false false R24.htm 996006 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.silopharma.com/role/CommitmentsandContingenciesTables Commitments and Contingencies (Tables) Tables http://www.silopharma.com/role/CommitmentsandContingencies 24 false false R25.htm 996007 - Disclosure - Income Taxes (Tables) Sheet http://www.silopharma.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.silopharma.com/role/IncomeTaxes 25 false false R26.htm 996008 - Disclosure - Organization and Business (Details) Sheet http://www.silopharma.com/role/OrganizationandBusinessDetails Organization and Business (Details) Details http://www.silopharma.com/role/OrganizationandBusiness 26 false false R27.htm 996009 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.silopharma.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details http://www.silopharma.com/role/SummaryofSignificantAccountingPoliciesTables 27 false false R28.htm 996010 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Shares (Details) Sheet http://www.silopharma.com/role/ScheduleofPotentiallyDilutiveSharesTable Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Shares (Details) Details 28 false false R29.htm 996011 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.silopharma.com/role/ScheduleofFinancialAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisTable Fair Value of Financial Instruments and Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 29 false false R30.htm 996012 - Disclosure - Fair Value of Financial Instruments and Fair Value Measurements - Schedule of Short-Term Investments, at Fair Value (Details) Sheet http://www.silopharma.com/role/ScheduleofShortTermInvestmentsatFairValueTable Fair Value of Financial Instruments and Fair Value Measurements - Schedule of Short-Term Investments, at Fair Value (Details) Details 30 false false R31.htm 996013 - Disclosure - Crypto Assets (Details) Sheet http://www.silopharma.com/role/CryptoAssetsDetails Crypto Assets (Details) Details http://www.silopharma.com/role/CryptoAssetsTables 31 false false R32.htm 996014 - Disclosure - Crypto Assets - Schedule of Fair Value of Crypto Assets Held Consolidated Balance Sheet (Details) Sheet http://www.silopharma.com/role/ScheduleofFairValueofCryptoAssetsHeldConsolidatedBalanceSheetTable Crypto Assets - Schedule of Fair Value of Crypto Assets Held Consolidated Balance Sheet (Details) Details 32 false false R33.htm 996015 - Disclosure - Crypto Assets - Schedule of Reconciliation of Crypto Assets (Details) Sheet http://www.silopharma.com/role/ScheduleofReconciliationofCryptoAssetsTable Crypto Assets - Schedule of Reconciliation of Crypto Assets (Details) Details 33 false false R34.htm 996016 - Disclosure - Intangible Assets (Details) Sheet http://www.silopharma.com/role/IntangibleAssetsDetails Intangible Assets (Details) Details http://www.silopharma.com/role/IntangibleAssetsTables 34 false false R35.htm 996017 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details) Sheet http://www.silopharma.com/role/ScheduleofIntangibleAssetsTable Intangible Assets - Schedule of Intangible Assets (Details) Details 35 false false R36.htm 996018 - Disclosure - Intangible Assets - Schedule of Intangible Assets With Finite Lives Attributable to Future Periods (Details) Sheet http://www.silopharma.com/role/ScheduleofIntangibleAssetsWithFiniteLivesAttributabletoFuturePeriodsTable Intangible Assets - Schedule of Intangible Assets With Finite Lives Attributable to Future Periods (Details) Details 36 false false R37.htm 996019 - Disclosure - Stockholders??? Equity (Details) Sheet http://www.silopharma.com/role/StockholdersEquityDetails Stockholders??? Equity (Details) Details http://www.silopharma.com/role/StockholdersEquityTables 37 false false R38.htm 996020 - Disclosure - Stockholders??? Equity - Schedule of Stock Option Activities (Details) Sheet http://www.silopharma.com/role/ScheduleofStockOptionActivitiesTable Stockholders??? Equity - Schedule of Stock Option Activities (Details) Details 38 false false R39.htm 996021 - Disclosure - Stockholders??? Equity - Schedule of Warrant Activities (Details) Sheet http://www.silopharma.com/role/ScheduleofWarrantActivitiesTable Stockholders??? Equity - Schedule of Warrant Activities (Details) Details 39 false false R40.htm 996022 - Disclosure - Concentrations (Details) Sheet http://www.silopharma.com/role/ConcentrationsDetails Concentrations (Details) Details http://www.silopharma.com/role/Concentrations 40 false false R41.htm 996023 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.silopharma.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.silopharma.com/role/CommitmentsandContingenciesTables 41 false false R42.htm 996024 - Disclosure - Commitments and Contingencies - Schedule of Future Amounts Due Under Sponsored Study and Research Agreements (Details) Sheet http://www.silopharma.com/role/ScheduleofFutureAmountsDueUnderSponsoredStudyandResearchAgreementsTable Commitments and Contingencies - Schedule of Future Amounts Due Under Sponsored Study and Research Agreements (Details) Details 42 false false R43.htm 996025 - Disclosure - Income Taxes (Details) Sheet http://www.silopharma.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.silopharma.com/role/IncomeTaxesTables 43 false false R44.htm 996026 - Disclosure - Income Taxes - Schedule of Components Of Loss Before Income Taxes (Details) Sheet http://www.silopharma.com/role/ScheduleofComponentsOfLossBeforeIncomeTaxesTable Income Taxes - Schedule of Components Of Loss Before Income Taxes (Details) Details 44 false false R45.htm 996027 - Disclosure - Income Taxes - Schedule of Effective Statutory Rate and the Provision for Income Taxes (Details) Sheet http://www.silopharma.com/role/ScheduleofEffectiveStatutoryRateandtheProvisionforIncomeTaxesTable Income Taxes - Schedule of Effective Statutory Rate and the Provision for Income Taxes (Details) Details 45 false false R46.htm 996028 - Disclosure - Income Taxes - Schedule of Net Deferred Tax Asset (Details) Sheet http://www.silopharma.com/role/ScheduleofNetDeferredTaxAssetTable Income Taxes - Schedule of Net Deferred Tax Asset (Details) Details 46 false false R47.htm 996029 - Disclosure - Subsequent Events (Details) Sheet http://www.silopharma.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.silopharma.com/role/SubsequentEvents 47 false false All Reports Book All Reports ea0285520-posam2_silopharma.htm silo-20251231.xsd silo-20251231_cal.xml silo-20251231_def.xml silo-20251231_lab.xml silo-20251231_pre.xml ea028552001_img1.jpg ea028552001_img2.jpg ea028552001_img3.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 true true